Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
31
datasets available to search
ShareScore release 0.9.0
Dataset results
31 results for “low-density lipoprotein cholesterol”
Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level
ClinicalTrials.gov study NCT00866229. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effects of Lowering Low-density Lipoprotein Cholesterol Levels to New Targets on Cardiovascular Complications in Peritoneal Dialysis Patients
ClinicalTrials.gov study NCT00999453. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low-density Lipoprotein Cholesterol Reduction With State-of-the-art Therapy in Secondary Prevention and Major Cardiovascular Adverse Events: Republic of Srpska Registry
ClinicalTrials.gov study NCT05081336. IPD Sharing: YES. Countries: 1. Publications: 0.
Evaluation of the Effectiveness of an Interdisciplinary Intervention After Acute Coronary Syndrome on Low-Density Lipoprotein Cholesterol Levels
ClinicalTrials.gov study NCT07178444. IPD Sharing: YES. Countries: 1. Publications: 0.
Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
ClinicalTrials.gov study NCT05660135. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol（LDL-C）
ClinicalTrials.gov study NCT07368608. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Ezetimibe on Oxidized Low-density Lipoprotein (LDL) Cholesterol
ClinicalTrials.gov study NCT01008345. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol
ClinicalTrials.gov study NCT05896969. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction
ClinicalTrials.gov study NCT02069106. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study to Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)
ClinicalTrials.gov study NCT06239714. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Data from: Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study
OBJECTIVES: The relationship between normal low-density lipoprotein cholesterol (LDL-c) levels and nonalcoholic fatty liver disease (NAFLD) in non-obese subjects remains unclear. We aimed to investigate the precise prevalence and incidence of NAFLD within the normal LDL-c range in non-obese subjects. Design: Cross-sectional and longitudinal study. Setting: Wenzhou Medical Center of Wenzhou People's Hospital from 2010 to 2014. Participants: 183903 non-obese individuals were enrolled from a cross-sectional population and a total of 16173 initially NAFLD-free non-obese subjects were included who completed a 5-year follow-up examination in the longitudinal population. RESULTS: In our study, NAFLD was defined by ultrasonographic detection of steatosis in the absence of other liver disease. The cross-sectional study showed that at baseline, the prevalence of NAFLD was 13.9% in non-obese subjects with normal LDL-c levels. The prospective study demonstrated that NAFLD-free subjects developed NAFLD during the 5-year follow-up period, with a cumulative incidence of 14.4%. In addition, the OR for NAFLD in the cross-sectional population were 1.11(95%CI 1.04-1.18), 1.37 (95%CI 1.27-1.47), and 1.56 (95%CI 1.43-1.69), respectively, after adjusting for known confounding variables. The HR for NAFLD in the longitudinal population were 1.15 (95%CI 0.98-1.36), 1.32 (95%CI 1.10-1.58) and 1.82 (95%CI 1.47-2.52), compared with Q1. Subjects with higher LDL-c level within the normal range had an increased cumulative incidence rate of NAFLD in non-obese subjects. CONCLUSIONS: NAFLD is prevalent in the non-obese Chinese population. Furthermore, this is the first study to demonstrate that increased normal LDL-c levels are independently associated with an elevated risk of NAFLD in non-obese subjects.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.